When close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 10x, you may consider AMOREPACIFIC Group (KRX:002790) as a stock to avoid entirely with its 29.1x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.
AMOREPACIFIC Group certainly has been doing a good job lately as its earnings growth has been positive while most other companies have been seeing their earnings go backwards. It seems that many are expecting the company to continue defying the broader market adversity, which has increased investors’ willingness to pay up for the stock. If not, then existing shareholders might be a little nervous about the viability of the share price.
See our latest analysis for AMOREPACIFIC Group
Keen to find out how analysts think AMOREPACIFIC Group's future stacks up against the industry? In that case, our free report is a great place to start.Is There Enough Growth For AMOREPACIFIC Group?
The only time you'd be truly comfortable seeing a P/E as steep as AMOREPACIFIC Group's is when the company's growth is on track to outshine the market decidedly.
Taking a look back first, we see that the company managed to grow earnings per share by a handy 8.5% last year. This was backed up an excellent period prior to see EPS up by 87% in total over the last three years. So we can start by confirming that the company has done a great job of growing earnings over that time.
Turning to the outlook, the next three years should generate growth of 44% per year as estimated by the six analysts watching the company. That's shaping up to be materially higher than the 20% per annum growth forecast for the broader market.
With this information, we can see why AMOREPACIFIC Group is trading at such a high P/E compared to the market. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.
The Bottom Line On AMOREPACIFIC Group's P/E
Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.
We've established that AMOREPACIFIC Group maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. Right now shareholders are comfortable with the P/E as they are quite confident future earnings aren't under threat. Unless these conditions change, they will continue to provide strong support to the share price.
Before you settle on your opinion, we've discovered 1 warning sign for AMOREPACIFIC Group that you should be aware of.
Of course, you might also be able to find a better stock than AMOREPACIFIC Group. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About KOSE:A002790
AMOREPACIFIC Group
Through its subsidiaries, engages in manufacturing, marketing, and trading of cosmetics, personal care goods, and other related products in Korea, Asia, North America, and internationally.
Undervalued with excellent balance sheet.